Monday, February 26, 2007

Health Canada examining information linking antiviral drug to development of treatment-resistant HIV

From Health Canada:
Health Canada is informing Canadians of new information submitted by the manufacturer of the antiviral drug Baraclude that suggests the drug may be linked to the development of a treatment-resistant strain of HIV in one patient with HIV.
For the Public
For Health Professionals

No comments: